Developing and validating an individualized breast cancer risk prediction model for women attending breast cancer screening. 2021

Javier Louro, and Marta Román, and Margarita Posso, and Ivonne Vázquez, and Francina Saladié, and Ana Rodriguez-Arana, and M Jesús Quintana, and Laia Domingo, and Marisa Baré, and Rafael Marcos-Gragera, and María Vernet-Tomas, and Maria Sala, and Xavier Castells, and
IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

Several studies have proposed personalized strategies based on women's individual breast cancer risk to improve the effectiveness of breast cancer screening. We designed and internally validated an individualized risk prediction model for women eligible for mammography screening. Retrospective cohort study of 121,969 women aged 50 to 69 years, screened at the long-standing population-based screening program in Spain between 1995 and 2015 and followed up until 2017. We used partly conditional Cox proportional hazards regression to estimate the adjusted hazard ratios (aHR) and individual risks for age, family history of breast cancer, previous benign breast disease, and previous mammographic features. We internally validated our model with the expected-to-observed ratio and the area under the receiver operating characteristic curve. During a mean follow-up of 7.5 years, 2,058 women were diagnosed with breast cancer. All three risk factors were strongly associated with breast cancer risk, with the highest risk being found among women with family history of breast cancer (aHR: 1.67), a proliferative benign breast disease (aHR: 3.02) and previous calcifications (aHR: 2.52). The model was well calibrated overall (expected-to-observed ratio ranging from 0.99 at 2 years to 1.02 at 20 years) but slightly overestimated the risk in women with proliferative benign breast disease. The area under the receiver operating characteristic curve ranged from 58.7% to 64.7%, depending of the time horizon selected. We developed a risk prediction model to estimate the short- and long-term risk of breast cancer in women eligible for mammography screening using information routinely reported at screening participation. The model could help to guiding individualized screening strategies aimed at improving the risk-benefit balance of mammography screening programs.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D012372 ROC Curve A graphic means for assessing the ability of a screening test to discriminate between healthy and diseased persons; may also be used in other studies, e.g., distinguishing stimuli responses as to a faint stimuli or nonstimuli. ROC Analysis,Receiver Operating Characteristic,Analysis, ROC,Analyses, ROC,Characteristic, Receiver Operating,Characteristics, Receiver Operating,Curve, ROC,Curves, ROC,ROC Analyses,ROC Curves,Receiver Operating Characteristics
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D016016 Proportional Hazards Models Statistical models used in survival analysis that assert that the effect of the study factors on the hazard rate in the study population is multiplicative and does not change over time. Cox Model,Cox Proportional Hazards Model,Hazard Model,Hazards Model,Hazards Models,Models, Proportional Hazards,Proportional Hazard Model,Proportional Hazards Model,Cox Models,Cox Proportional Hazards Models,Hazard Models,Proportional Hazard Models,Hazard Model, Proportional,Hazard Models, Proportional,Hazards Model, Proportional,Hazards Models, Proportional,Model, Cox,Model, Hazard,Model, Hazards,Model, Proportional Hazard,Model, Proportional Hazards,Models, Cox,Models, Hazard,Models, Hazards,Models, Proportional Hazard

Related Publications

Javier Louro, and Marta Román, and Margarita Posso, and Ivonne Vázquez, and Francina Saladié, and Ana Rodriguez-Arana, and M Jesús Quintana, and Laia Domingo, and Marisa Baré, and Rafael Marcos-Gragera, and María Vernet-Tomas, and Maria Sala, and Xavier Castells, and
November 2023, Journal of the National Cancer Institute,
Javier Louro, and Marta Román, and Margarita Posso, and Ivonne Vázquez, and Francina Saladié, and Ana Rodriguez-Arana, and M Jesús Quintana, and Laia Domingo, and Marisa Baré, and Rafael Marcos-Gragera, and María Vernet-Tomas, and Maria Sala, and Xavier Castells, and
September 2006, Journal of the National Cancer Institute,
Javier Louro, and Marta Román, and Margarita Posso, and Ivonne Vázquez, and Francina Saladié, and Ana Rodriguez-Arana, and M Jesús Quintana, and Laia Domingo, and Marisa Baré, and Rafael Marcos-Gragera, and María Vernet-Tomas, and Maria Sala, and Xavier Castells, and
October 2021, European journal of oncology nursing : the official journal of European Oncology Nursing Society,
Javier Louro, and Marta Román, and Margarita Posso, and Ivonne Vázquez, and Francina Saladié, and Ana Rodriguez-Arana, and M Jesús Quintana, and Laia Domingo, and Marisa Baré, and Rafael Marcos-Gragera, and María Vernet-Tomas, and Maria Sala, and Xavier Castells, and
January 2017, Breast cancer research and treatment,
Javier Louro, and Marta Román, and Margarita Posso, and Ivonne Vázquez, and Francina Saladié, and Ana Rodriguez-Arana, and M Jesús Quintana, and Laia Domingo, and Marisa Baré, and Rafael Marcos-Gragera, and María Vernet-Tomas, and Maria Sala, and Xavier Castells, and
August 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,
Javier Louro, and Marta Román, and Margarita Posso, and Ivonne Vázquez, and Francina Saladié, and Ana Rodriguez-Arana, and M Jesús Quintana, and Laia Domingo, and Marisa Baré, and Rafael Marcos-Gragera, and María Vernet-Tomas, and Maria Sala, and Xavier Castells, and
March 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Javier Louro, and Marta Román, and Margarita Posso, and Ivonne Vázquez, and Francina Saladié, and Ana Rodriguez-Arana, and M Jesús Quintana, and Laia Domingo, and Marisa Baré, and Rafael Marcos-Gragera, and María Vernet-Tomas, and Maria Sala, and Xavier Castells, and
January 2023, Cancers,
Javier Louro, and Marta Román, and Margarita Posso, and Ivonne Vázquez, and Francina Saladié, and Ana Rodriguez-Arana, and M Jesús Quintana, and Laia Domingo, and Marisa Baré, and Rafael Marcos-Gragera, and María Vernet-Tomas, and Maria Sala, and Xavier Castells, and
October 2020, European radiology,
Javier Louro, and Marta Román, and Margarita Posso, and Ivonne Vázquez, and Francina Saladié, and Ana Rodriguez-Arana, and M Jesús Quintana, and Laia Domingo, and Marisa Baré, and Rafael Marcos-Gragera, and María Vernet-Tomas, and Maria Sala, and Xavier Castells, and
May 2021, Revue medicale de Liege,
Javier Louro, and Marta Román, and Margarita Posso, and Ivonne Vázquez, and Francina Saladié, and Ana Rodriguez-Arana, and M Jesús Quintana, and Laia Domingo, and Marisa Baré, and Rafael Marcos-Gragera, and María Vernet-Tomas, and Maria Sala, and Xavier Castells, and
November 2022, International journal of cancer,
Copied contents to your clipboard!